Crispr Stock, A Cathie Wood’s Holding, Dives For The Fifth Straight Week — Here’s Why

Crispr stock is tumbling for the fifth straight week as the top Cathie Wood’s holding struggles amid dimming expectations for its new Vertex-partnered gene-editing drug. X Crispr Therapeutics (CRSP) and Vertex Pharmaceuticals (VRTX) gained Food and Drug Administration approval for Casgevy on Dec. 8. On the same day, the FDA signed off on a rival … Read more

California proposal would change how power bills are calculated, aiming to relieve summer spikes

SACRAMENTO, Calif. (AP) — It’s become a rite of summer in sunny California: When the temperature spikes, so do electricity bills, leaving some customers with monthly payments over $500. A big reason for that is the way California’s largest power companies calculate rates. The more power you use, the more money you pay — not … Read more